Davidbrownm05
New member
The duration of raloxifene 60 mg tablet treatment for osteoporosis typically depends on individual risk factors, treatment response, and healthcare provider recommendations. Clinical trials have shown that raloxifene reduces the risk of vertebral fractures in postmenopausal women with osteoporosis over three years of treatment. However, there is no consensus on the optimal duration of raloxifene therapy. Healthcare providers may reassess the need for continued treatment based on bone density measurements, fracture risk assessment, and potential side effects. It's essential for individuals to discuss treatment duration and follow-up plans with their healthcare provider to ensure optimal management of osteoporosis.